This article will help you read and understand your pathology report for squamous cell carcinoma of the oral cavity.
by Jason Wasserman, MD PhD FRCPC, reviewed on May 20, 2020
The oral cavity is the beginning of the aerodigestive tract. It is used for both breathing and taking in food. The oral cavity is a complex area of the body that is made up of many parts (see picture below).
The oral cavity includes:
The surface of the oral cavity is lined by specialized cells called squamous cells. that create a barrier called the epithelium. The tissue below the epithelium is called stroma. The epithelium is separated from the stroma by a thin strip of tissue called the basement membrane. Pathologists use the word mucosa to describe all of the tissue above the stroma.
Squamous cell carcinoma is a type of cancer that starts from the squamous cells in the epithelium. Squamous cell carcinoma is the most common type of cancer to start in the oral cavity. This tumour can start anywhere in the oral cavity although most start on the side of the tongue (lateral tongue) or the bottom (floor) of the mouth.
Most squamous cell carcinomas of the oral cavity are described as keratinizing because the cancer cells produce a protein called keratin which is normally found in the skin but not in the oral cavity.
Squamous cell carcinoma in the oral cavity often starts from a pre-cancerous disease called squamous dysplasia. Squamous dysplasia may be present for many years before turning into squamous cell carcinoma.
When examined under a microscope, the abnormal cells in squamous dysplasia are only found in the epithelium on the surface of the oral cavity. In order to become squamous cell carcinoma, the cancer cells have to move from the epithelium into the stroma below. The movement of cancer cells from the epithelium into the stroma below is called invasion.
Smoking and high levels of alcohol consumption increase the risk for developing both squamous cell carcinoma and squamous dysplasia.
A biopsy is a surgical procedure that removes a small piece of tissue for examination by a pathologist. The purpose of a biopsy is to establish a diagnosis. A test called immunohistochemistry may be performed to confirm the diagnosis.
Your biopsy report may describe the histologic grade of the tumour (see Histologic grade below). Your doctors will use this information to plan treatment such as surgery, radiation, and chemotherapy.
After the tumour has been removed completely, it will be sent to a pathologist who will prepare another pathology report. This report will confirm or revise the original diagnosis and provide additional important information such tumour size, depth of invasion, and spread of tumour cells to lymph nodes. This information is used to determine the cancer stage and to decide if additional treatment is required. Continue reading to learn more about the information found in this report.
The type of surgery performed to remove a tumour from the oral cavity will depend on the location and size of the tumour. Some procedures are given special names which tell the pathologist what kind of tissue was removed.
Here is a list of some common special procedures performed to remove tumours from the oral cavity:
The grade is divided into three levels of differentiation based on how the cancer cells look when examined under the microscope:
Grade is important because poorly differentiated tumours are often associated with a worse prognosis.
This is the size of the tumour. Tumour size will only be described in your report after the entire tumour has been removed. The tumour is usually measured in three dimensions but only the largest dimension is described in your report. For example, if the tumour measures 4.0 cm by 2.0 cm by 1.5 cm, your report will describe the tumour as being 4.0 cm.
The tumour size is used to determine the tumour stage (see Pathologic stage below) and larger tumours are associated with worse prognosis.
All squamous cell carcinomas start in the epithelium on the surface of the oral cavity. Depth of invasion is a measurement of how far the cancer cells have traveled from the epithelium into the stroma below.
Tumours with a depth of invasion greater than 0.5 centimeters (5 millimeters) are associated with a higher risk that the tumour will come back at the same site after treatment or that cancer cells will be found in a lymph node. The depth of invasion is used to determine the tumour stage (see Pathologic stage below).
Nerves are like long wires made up of groups of cells called neurons. Nerves send information (such as temperature, pressure, and pain) between your brain and your body. Perineural invasion means that cancer cells were seen attached to a nerve.
Cancer cells that have attached to a nerve can use the nerve to travel into tissue outside of the original tumour. This increases the risk that the tumour will come back in the same area of the body (recurrence) after treatment.
Blood moves around the body through long thin tubes called blood vessels. Another type of fluid called lymph which contains waste and immune cells moves around the body through lymphatic channels.
Cancer cells can use blood vessels and lymphatics to travel away from the tumour to other parts of the body. The movement of cancer cells from the tumour to another part of the body is called metastasis. Before cancer cells can metastasize, they need to enter a blood vessel or lymphatic. This is called lymphovascular invasion.
Lymphovascular invasion increases the risk that cancer cells will be found in a lymph node or a distant part of the body such as the lungs.
A margin is any tissue that was cut by the surgeon in order to remove the tumour from your body. The types of margins described in your report will depend on the organ involved and the type of surgery performed. Margins will only be described in your report after the entire tumour has been removed.
A margin is called positive when there are tumour cells at the very edge of the cut tissue. A positive margin is associated with a higher risk that the tumour will recur in the same site after treatment. A negative margin means that no tumour cells were seen at any of the cut edges of tissue.
Lymph nodes are small immune organs located throughout the body. Cancer cells can travel from the tumour to a lymph node through lymphatic channels located in and around the tumour (see Lymphovascular invasion above). The movement of cancer cells from the tumour to a lymph node is called a metastasis.
Lymph nodes from the neck are sometimes removed at the same time as the main tumour in a procedure called a neck dissection. The lymph nodes removed usually come from different areas of the neck and each area is called a level. The levels in the neck include 1, 2, 3, 4, and 5. Your pathology report will often describe how many lymph nodes were seen in each level sent for examination.
Lymph nodes on the same side as the tumour are called ipsilateral while those on the opposite side of the tumour are called contralateral.
Your pathologist will carefully examine each lymph node for cancer cells. Lymph nodes that contain cancer cells are often called positive while those that do not contain any cancer cells are called negative. Most reports include the total number of lymph nodes examined and the number, if any, that contain cancer cells.
A group of cancer cells inside of a lymph node is called a tumour deposit. If a tumour deposit is found, your pathologist will measure the deposit and the largest tumour deposit found will be described in your report.
Larger tumour deposits are associated with worse prognosis. The size of the largest tumour deposit is also used to determine the nodal stage (see Pathologic stage below).
All lymph nodes are surrounded by a capsule. Extranodal extension (ENE) means that cancer cells have broken through the capsule and into the tissue that surrounds the lymph node.
Extranodal extension is also associated with a higher risk of new tumours developing in the neck and is often used by your doctors to guide your treatment. Extranodal extension is also used to determine the nodal stage (see Pathologic stage below).
The pathologic stage for squamous cell carcinoma is based on the TNM staging system, an internationally recognized system originally created by the American Joint Committee on Cancer.
This system uses information about the primary tumour (T), lymph nodes (N), and distant metastatic disease (M) to determine the complete pathologic stage (pTNM). Your pathologist will examine the tissue submitted and give each part a number. In general, a higher number means more advanced disease and worse prognosis.
Tumour stage (pT) for squamous cell carcinoma
Your pathologist will look for three features in order to determine the tumour stage:
Based on these features, squamous cell carcinoma is given a tumour stage between 1 and 4:
Nodal stage (pN) for squamous cell carcinoma
Your pathologist will look for four features in order to determine the nodal stage:
Based on these features, squamous cell carcinoma is given an nodal stage between 0 and 3. The N2 and N3 stages are divided into smaller groups with letters (a, b, or c) after the number.
If no lymph nodes are submitted for pathological examination, the N-stage cannot be determined and the N stage is listed as X.
Metastatic stage (pM) for squamous cell carcinoma
Squamous cell carcinoma is given a metastatic stage of 0 or 1 based on the presence of cancer cells at a distant site in the body (for example the lungs). The metastatic stage can only be assigned if tissue from a distant site is sent for pathological examination. Because this tissue is rarely present, the metastatic stage cannot be determined and is listed as MX.